3D Bioprinting-EMEA Market Status and Trend Report 2013-2023
Report Summary
3D Bioprinting-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on 3D Bioprinting industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of 3D Bioprinting 2013-2017, and development forecast 2018-2023
Main market players of 3D Bioprinting in EMEA, with company and product introduction, position in the 3D Bioprinting market
Market status and development trend of 3D Bioprinting by types and applications
Cost and profit status of 3D Bioprinting, and marketing status
Market growth drivers and challenges
The report segments the EMEA 3D Bioprinting market as:
EMEA 3D Bioprinting Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA 3D Bioprinting Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
EMEA 3D Bioprinting Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
EMEA 3D Bioprinting Market: Players Segment Analysis (Company and Product introduction, 3D Bioprinting Sales Volume, Revenue, Price and Gross Margin):
Organovo Holdings Inc.
EnvisionTEC GmbH
Nano3D Biosciences, Inc.
Cyfuse Biomedical K.K.
BioBots
Aspect Biosystems Ltd.
3Dynamic Systems Ltd.
regenHU Ltd
Cellink
Regenovo Biotechnology Co., Ltd.
Poietis
GeSiM
Exone
Stratasys
Bespoke Innovations
Advanced BioMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
3D Bioprinting-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on 3D Bioprinting industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of 3D Bioprinting 2013-2017, and development forecast 2018-2023
Main market players of 3D Bioprinting in EMEA, with company and product introduction, position in the 3D Bioprinting market
Market status and development trend of 3D Bioprinting by types and applications
Cost and profit status of 3D Bioprinting, and marketing status
Market growth drivers and challenges
The report segments the EMEA 3D Bioprinting market as:
EMEA 3D Bioprinting Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA 3D Bioprinting Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
EMEA 3D Bioprinting Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinical Applications
Research Applications
Drug and Medical Research
Regenerative Medicine
3D Cell Culture
EMEA 3D Bioprinting Market: Players Segment Analysis (Company and Product introduction, 3D Bioprinting Sales Volume, Revenue, Price and Gross Margin):
Organovo Holdings Inc.
EnvisionTEC GmbH
Nano3D Biosciences, Inc.
Cyfuse Biomedical K.K.
BioBots
Aspect Biosystems Ltd.
3Dynamic Systems Ltd.
regenHU Ltd
Cellink
Regenovo Biotechnology Co., Ltd.
Poietis
GeSiM
Exone
Stratasys
Bespoke Innovations
Advanced BioMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF 3D BIOPRINTING
1.1 Definition of 3D Bioprinting in This Report
1.2 Commercial Types of 3D Bioprinting
1.2.1 Magnetic 3D Bioprinting
1.2.2 Laser-assisted Bioprinting
1.2.3 Inkjet 3D Bioprinting
1.2.4 Microextrusion 3D Bioprinting
1.3 Downstream Application of 3D Bioprinting
1.3.1 Clinical Applications
1.3.2 Research Applications
1.3.3 Drug and Medical Research
1.3.4 Regenerative Medicine
1.3.5 3D Cell Culture
1.4 Development History of 3D Bioprinting
1.5 Market Status and Trend of 3D Bioprinting 2013-2023
1.5.1 EMEA 3D Bioprinting Market Status and Trend 2013-2023
1.5.2 Regional 3D Bioprinting Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of 3D Bioprinting in EMEA 2013-2017
2.2 Consumption Market of 3D Bioprinting in EMEA by Regions
2.2.1 Consumption Volume of 3D Bioprinting in EMEA by Regions
2.2.2 Revenue of 3D Bioprinting in EMEA by Regions
2.3 Market Analysis of 3D Bioprinting in EMEA by Regions
2.3.1 Market Analysis of 3D Bioprinting in Europe 2013-2017
2.3.2 Market Analysis of 3D Bioprinting in Middle East 2013-2017
2.3.3 Market Analysis of 3D Bioprinting in Africa 2013-2017
2.4 Market Development Forecast of 3D Bioprinting in EMEA 2018-2023
2.4.1 Market Development Forecast of 3D Bioprinting in EMEA 2018-2023
2.4.2 Market Development Forecast of 3D Bioprinting by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of 3D Bioprinting in EMEA by Types
3.1.2 Revenue of 3D Bioprinting in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of 3D Bioprinting in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of 3D Bioprinting in EMEA by Downstream Industry
4.2 Demand Volume of 3D Bioprinting by Downstream Industry in Major Countries
4.2.1 Demand Volume of 3D Bioprinting by Downstream Industry in Europe
4.2.2 Demand Volume of 3D Bioprinting by Downstream Industry in Middle East
4.2.3 Demand Volume of 3D Bioprinting by Downstream Industry in Africa
4.3 Market Forecast of 3D Bioprinting in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF 3D BIOPRINTING
5.1 EMEA Economy Situation and Trend Overview
5.2 3D Bioprinting Downstream Industry Situation and Trend Overview
CHAPTER 6 3D BIOPRINTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of 3D Bioprinting in EMEA by Major Players
6.2 Revenue of 3D Bioprinting in EMEA by Major Players
6.3 Basic Information of 3D Bioprinting by Major Players
6.3.1 Headquarters Location and Established Time of 3D Bioprinting Major Players
6.3.2 Employees and Revenue Level of 3D Bioprinting Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 3D BIOPRINTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Organovo Holdings Inc.
7.1.1 Company profile
7.1.2 Representative 3D Bioprinting Product
7.1.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Organovo Holdings Inc.
7.2 EnvisionTEC GmbH
7.2.1 Company profile
7.2.2 Representative 3D Bioprinting Product
7.2.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of EnvisionTEC GmbH
7.3 Nano3D Biosciences, Inc.
7.3.1 Company profile
7.3.2 Representative 3D Bioprinting Product
7.3.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Nano3D Biosciences, Inc.
7.4 Cyfuse Biomedical K.K.
7.4.1 Company profile
7.4.2 Representative 3D Bioprinting Product
7.4.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cyfuse Biomedical K.K.
7.5 BioBots
7.5.1 Company profile
7.5.2 Representative 3D Bioprinting Product
7.5.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of BioBots
7.6 Aspect Biosystems Ltd.
7.6.1 Company profile
7.6.2 Representative 3D Bioprinting Product
7.6.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Aspect Biosystems Ltd.
7.7 3Dynamic Systems Ltd.
7.7.1 Company profile
7.7.2 Representative 3D Bioprinting Product
7.7.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of 3Dynamic Systems Ltd.
7.8 regenHU Ltd
7.8.1 Company profile
7.8.2 Representative 3D Bioprinting Product
7.8.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of regenHU Ltd
7.9 Cellink
7.9.1 Company profile
7.9.2 Representative 3D Bioprinting Product
7.9.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cellink
7.10 Regenovo Biotechnology Co., Ltd.
7.10.1 Company profile
7.10.2 Representative 3D Bioprinting Product
7.10.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Regenovo Biotechnology Co., Ltd.
7.11 Poietis
7.11.1 Company profile
7.11.2 Representative 3D Bioprinting Product
7.11.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Poietis
7.12 GeSiM
7.12.1 Company profile
7.12.2 Representative 3D Bioprinting Product
7.12.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of GeSiM
7.13 Exone
7.13.1 Company profile
7.13.2 Representative 3D Bioprinting Product
7.13.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Exone
7.14 Stratasys
7.14.1 Company profile
7.14.2 Representative 3D Bioprinting Product
7.14.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Stratasys
7.15 Bespoke Innovations
7.15.1 Company profile
7.15.2 Representative 3D Bioprinting Product
7.15.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Bespoke Innovations
7.16 Advanced BioMatrix
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF 3D BIOPRINTING
8.1 Industry Chain of 3D Bioprinting
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF 3D BIOPRINTING
9.1 Cost Structure Analysis of 3D Bioprinting
9.2 Raw Materials Cost Analysis of 3D Bioprinting
9.3 Labor Cost Analysis of 3D Bioprinting
9.4 Manufacturing Expenses Analysis of 3D Bioprinting
CHAPTER 10 MARKETING STATUS ANALYSIS OF 3D BIOPRINTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of 3D Bioprinting in This Report
1.2 Commercial Types of 3D Bioprinting
1.2.1 Magnetic 3D Bioprinting
1.2.2 Laser-assisted Bioprinting
1.2.3 Inkjet 3D Bioprinting
1.2.4 Microextrusion 3D Bioprinting
1.3 Downstream Application of 3D Bioprinting
1.3.1 Clinical Applications
1.3.2 Research Applications
1.3.3 Drug and Medical Research
1.3.4 Regenerative Medicine
1.3.5 3D Cell Culture
1.4 Development History of 3D Bioprinting
1.5 Market Status and Trend of 3D Bioprinting 2013-2023
1.5.1 EMEA 3D Bioprinting Market Status and Trend 2013-2023
1.5.2 Regional 3D Bioprinting Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of 3D Bioprinting in EMEA 2013-2017
2.2 Consumption Market of 3D Bioprinting in EMEA by Regions
2.2.1 Consumption Volume of 3D Bioprinting in EMEA by Regions
2.2.2 Revenue of 3D Bioprinting in EMEA by Regions
2.3 Market Analysis of 3D Bioprinting in EMEA by Regions
2.3.1 Market Analysis of 3D Bioprinting in Europe 2013-2017
2.3.2 Market Analysis of 3D Bioprinting in Middle East 2013-2017
2.3.3 Market Analysis of 3D Bioprinting in Africa 2013-2017
2.4 Market Development Forecast of 3D Bioprinting in EMEA 2018-2023
2.4.1 Market Development Forecast of 3D Bioprinting in EMEA 2018-2023
2.4.2 Market Development Forecast of 3D Bioprinting by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of 3D Bioprinting in EMEA by Types
3.1.2 Revenue of 3D Bioprinting in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of 3D Bioprinting in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of 3D Bioprinting in EMEA by Downstream Industry
4.2 Demand Volume of 3D Bioprinting by Downstream Industry in Major Countries
4.2.1 Demand Volume of 3D Bioprinting by Downstream Industry in Europe
4.2.2 Demand Volume of 3D Bioprinting by Downstream Industry in Middle East
4.2.3 Demand Volume of 3D Bioprinting by Downstream Industry in Africa
4.3 Market Forecast of 3D Bioprinting in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF 3D BIOPRINTING
5.1 EMEA Economy Situation and Trend Overview
5.2 3D Bioprinting Downstream Industry Situation and Trend Overview
CHAPTER 6 3D BIOPRINTING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of 3D Bioprinting in EMEA by Major Players
6.2 Revenue of 3D Bioprinting in EMEA by Major Players
6.3 Basic Information of 3D Bioprinting by Major Players
6.3.1 Headquarters Location and Established Time of 3D Bioprinting Major Players
6.3.2 Employees and Revenue Level of 3D Bioprinting Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 3D BIOPRINTING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Organovo Holdings Inc.
7.1.1 Company profile
7.1.2 Representative 3D Bioprinting Product
7.1.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Organovo Holdings Inc.
7.2 EnvisionTEC GmbH
7.2.1 Company profile
7.2.2 Representative 3D Bioprinting Product
7.2.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of EnvisionTEC GmbH
7.3 Nano3D Biosciences, Inc.
7.3.1 Company profile
7.3.2 Representative 3D Bioprinting Product
7.3.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Nano3D Biosciences, Inc.
7.4 Cyfuse Biomedical K.K.
7.4.1 Company profile
7.4.2 Representative 3D Bioprinting Product
7.4.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cyfuse Biomedical K.K.
7.5 BioBots
7.5.1 Company profile
7.5.2 Representative 3D Bioprinting Product
7.5.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of BioBots
7.6 Aspect Biosystems Ltd.
7.6.1 Company profile
7.6.2 Representative 3D Bioprinting Product
7.6.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Aspect Biosystems Ltd.
7.7 3Dynamic Systems Ltd.
7.7.1 Company profile
7.7.2 Representative 3D Bioprinting Product
7.7.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of 3Dynamic Systems Ltd.
7.8 regenHU Ltd
7.8.1 Company profile
7.8.2 Representative 3D Bioprinting Product
7.8.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of regenHU Ltd
7.9 Cellink
7.9.1 Company profile
7.9.2 Representative 3D Bioprinting Product
7.9.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Cellink
7.10 Regenovo Biotechnology Co., Ltd.
7.10.1 Company profile
7.10.2 Representative 3D Bioprinting Product
7.10.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Regenovo Biotechnology Co., Ltd.
7.11 Poietis
7.11.1 Company profile
7.11.2 Representative 3D Bioprinting Product
7.11.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Poietis
7.12 GeSiM
7.12.1 Company profile
7.12.2 Representative 3D Bioprinting Product
7.12.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of GeSiM
7.13 Exone
7.13.1 Company profile
7.13.2 Representative 3D Bioprinting Product
7.13.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Exone
7.14 Stratasys
7.14.1 Company profile
7.14.2 Representative 3D Bioprinting Product
7.14.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Stratasys
7.15 Bespoke Innovations
7.15.1 Company profile
7.15.2 Representative 3D Bioprinting Product
7.15.3 3D Bioprinting Sales, Revenue, Price and Gross Margin of Bespoke Innovations
7.16 Advanced BioMatrix
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF 3D BIOPRINTING
8.1 Industry Chain of 3D Bioprinting
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF 3D BIOPRINTING
9.1 Cost Structure Analysis of 3D Bioprinting
9.2 Raw Materials Cost Analysis of 3D Bioprinting
9.3 Labor Cost Analysis of 3D Bioprinting
9.4 Manufacturing Expenses Analysis of 3D Bioprinting
CHAPTER 10 MARKETING STATUS ANALYSIS OF 3D BIOPRINTING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
